LIVERMULTISCAN
LIVE

Serial Number

50134502

Owner

Perspectum Ltd.

Attorney

Paul Cosmovici

First Use Date

Sep 6, 2022

Filing Date

Sep 29, 2026

Add to watchlist:

No watchlists yet
View on USPTO

LIVERMULTISCAN Trademark

Serial Number: 50134502

LIVERMULTISCAN is a trademark filed by Perspectum Ltd. on September 29, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Perspectum Ltd.

5520 John Smith Drive
Oxford OX4 2LL , GB

Entity Type: 24

Trademark Details

Filing Date

September 29, 2026

Registration Date

Not Registered

First Use Anywhere

September 6, 2022

First Use in Commerce

September 6, 2022

Goods & Services

Software as a service (SAAS) services featuring software for identification and monitoring of disease in clinical trials; Software as a service (SAAS) services featuring software for use in medical imaging analysis, clinical trials management, and generation of diagnostic and research reports; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for the analysis of digital images of the anatomy for diagnosis and treatment; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of biomarkers; Medical research; Technical research in the field of pharmaceutical studies; Technical consulting in the field of pharmaceutical studies; Providing medical and scientific research information in the field of clinical trials

Downloadable Software as a Medical Device (SaMD) for diagnosing and monitoring liver disease; Recorded Software as a Medical Device (SaMD) for diagnosing and monitoring liver disease; Downloadable Software as a Medical Device (SaMD) for diagnosing and monitoring disease in the field of oncology; Downloadable Software as a Medical Device (SaMD) for diagnosing and monitoring metabolic health and body composition; Recorded Software as a Medical Device (SaMD) for diagnosing and monitoring multiorgan diseases; Recorded Software as a Medical Device (SaMD) for diagnosing and monitoring cardiovascular disease; Recorded Software as a Medical Device (SaMD) for diagnosing and monitoring autoimmune disease; Recorded Software as a Medical Device (SaMD) for diagnosing and monitoring gastrointestinal and bowel disease; Recorded Software as a Medical Device (SaMD) for diagnosing and monitoring disease in the field of oncology

Medical imaging services; Medical analysis services relating to the treatment of persons; Medical analysis for the diagnosis and treatment of persons; Medical analysis services relating to the treatment of patients; Clinical medical consultation services; Consulting services in the field of medical care; Pharmaceutical advice; Providing medical information, consultancy and advisory services

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 29, 2026 MAFR
NEW APPLICATION ENTERED
Sep 29, 2026 NWAP